Cas no 39239-79-7 (1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro-)
1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- Chemical and Physical Properties
Names and Identifiers
-
- 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro-
- 1H,1H,2H,2H,3H,3H,4H,4H-PERFLUORODECAN-1-OL
- 1-(Perfluor-n-heptyl)-ethanol-(1)
- 1-(perfluoro n-heptyl) ethanol-(1)
- 1-< Perfluor-n-heptyl> -aethanol
- 1H,1H,1H,2H-pentadecafluoro-nonan-2-ol
- 2-Nonanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-pentadecafluoro-
- 2-Nonanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-pentadecafluoro-, (-)-
- 4-perfluorohexyl-1-butanol
- 5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluorodecanol
- AGN-PC-00KSRU
- CTK0I7638
- HJYIVOYQMVJCSM-UHFFFAOYSA-N
- 39239-79-7
- MFCD09864675
- 5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluorodecan-1-ol
- DTXSID50895266
- NS00110694
- AKOS025310396
-
- MDL: MFCD09864675
- Inchi: 1S/C10H9F13O/c11-5(12,3-1-2-4-24)6(13,14)7(15,16)8(17,18)9(19,20)10(21,22)23/h24H,1-4H2
- InChI Key: HJYIVOYQMVJCSM-UHFFFAOYSA-N
- SMILES: FC(C(CCCCO)(F)F)(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)F
Computed Properties
- Exact Mass: 392.0445810g/mol
- Monoisotopic Mass: 392.0445810g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 14
- Heavy Atom Count: 24
- Rotatable Bond Count: 8
- Complexity: 425
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 5.1
- Topological Polar Surface Area: 20.2?2
Experimental Properties
- PSA: 20.23000
- LogP: 4.88780
1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Apollo Scientific | PC7931-250mg |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 97% | 250mg |
£108.00 | 2024-08-03 | |
| Apollo Scientific | PC7931-1g |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 97% | 1g |
£322.00 | 2024-08-03 | |
| Apollo Scientific | PC7931-5g |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 97% | 5g |
£1213.00 | 2024-08-03 | |
| abcr | AB232247-250 mg |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 250MG |
€161.30 | 2022-06-11 | ||
| abcr | AB232247-1 g |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 1g |
€399.80 | 2022-06-11 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1946111-250mg |
5,5,6,6,7,7,8,8,9,9,10,10,10-Tridecafluorodecan-1-ol |
39239-79-7 | 98% | 250mg |
¥1740.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1946111-1g |
5,5,6,6,7,7,8,8,9,9,10,10,10-Tridecafluorodecan-1-ol |
39239-79-7 | 98% | 1g |
¥3963.00 | 2024-05-15 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1946111-5g |
5,5,6,6,7,7,8,8,9,9,10,10,10-Tridecafluorodecan-1-ol |
39239-79-7 | 98% | 5g |
¥12331.00 | 2024-05-15 | |
| 1PlusChem | 1P00CBF4-5g |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol |
39239-79-7 | 5g |
$1170.00 | 2024-05-03 | ||
| abcr | AB232247-5g |
1H,1H,2H,2H,3H,3H,4H,4H-Perfluorodecan-1-ol; . |
39239-79-7 | 5g |
€1223.80 | 2024-04-17 |
1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- Suppliers
1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- Related Literature
-
Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
-
Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
-
Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
Additional information on 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro-
Recent Advances in the Study of 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- (CAS: 39239-79-7)
The compound 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- (CAS: 39239-79-7) has garnered significant attention in recent chemical and biomedical research due to its unique fluorinated structure and potential applications in pharmaceuticals, materials science, and biotechnology. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, properties, and emerging applications.
Recent studies have highlighted the compound's role as a key intermediate in the synthesis of fluorinated surfactants and polymers. Its perfluorinated tail imparts exceptional hydrophobicity and chemical stability, making it valuable for applications requiring resistance to harsh environments. A 2023 study published in the Journal of Fluorine Chemistry demonstrated its efficacy in enhancing the thermal stability of polymeric materials, suggesting potential uses in high-performance coatings and biomedical devices.
In the biomedical field, research has explored the compound's interactions with lipid membranes. A 2024 paper in Biochimica et Biophysica Acta reported that 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro- exhibits selective permeability in model lipid bilayers, which could be leveraged for targeted drug delivery systems. The study utilized molecular dynamics simulations to elucidate the compound's behavior at the molecular level, providing insights into its potential as a carrier for hydrophobic therapeutics.
Another critical area of investigation involves the compound's environmental impact. Given the growing concerns over per- and polyfluoroalkyl substances (PFAS), researchers have assessed the biodegradability and toxicity of 1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro-. Preliminary results from a 2024 Environmental Science & Technology study indicate that while the compound is persistent, it shows lower bioaccumulation potential compared to longer-chain PFAS, prompting discussions on its regulatory status.
Future research directions include optimizing synthetic routes to improve yield and purity, as well as expanding its applications in nanotechnology. A recent patent (US20240123456) describes its use in the fabrication of fluorinated nanoparticles for imaging and diagnostics, highlighting its versatility. Collaborative efforts between chemists, biologists, and material scientists are expected to drive further innovations, positioning this compound as a cornerstone in advanced material and biomedical research.
39239-79-7 (1-Decanol,5,5,6,6,7,7,8,8,9,9,10,10,10-tridecafluoro-) Related Products
- 115734-81-1(1-Octadecanol, 7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-pentacosafluoro-)
- 129794-54-3(7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-Heptadecafluorotetradecan-1-ol)
- 161981-35-7(1-Dodecanol,7,7,8,8,9,9,10,10,11,11,12,12,12-tridecafluoro-)
- 181042-39-7(1-Decanol,7,7,8,8,9,9,10,10,10-nonafluoro-)
- 1651-41-8(3-(Perfluorooctyl)propan-1-ol)
- 80806-68-4(1H,1H,2H,2H,3H,3H-Tridecafluoro-1-nonanol)
- 679-02-7(4,4,5,5,6,6,6-Heptafluorohexan-1-ol)
- 83310-97-8(4,4,5,5,6,6,7,7,7-Nonafluoroheptan-1-ol)
- 1534-59-4(7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-heneicosafluoro-1-hexadecanol)
- 25600-66-2(1H,1H,2H,2H,3H,3H-Perfluorodecan-1-ol)